Organon & Co. — Director's Dealing 2025

Aug 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2025-08-11

Reporting Person: Arjona Ferreira Juan Camilo (Head of R&D & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-11	Common Stock	M	11519	—	Acquired	28899.355	Direct
2025-08-11	Common Stock	F	4122	$9.22	Disposed	24777.355	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-11	Restricted Stock Units	$	M	11519	Disposed	2026-08-11	Common Stock (11519)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Organon common stock.

F2: These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments with 11,519 shares having vested on August 11, 2025 and the third and final vesting to occur on August 11, 2026.